Covered recipient · General Payments record
DANIEL E MENDEZ ALLWOOD
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$679.80
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $421.93 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $158.38 | 8 |
| ABBVIE INC. | $101.27 | 5 |
| Organon LLC | $59.45 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $38.09 | 2 |
| GENZYME CORPORATION | $24.75 | 1 |
| Sandoz Inc. | $24.70 | 1 |
| Celgene Corporation | $15.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.04 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105021370 | CMS |
| ABBVIE INC. | $23.62 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105021372 | CMS |
| ABBVIE INC. | $17.67 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105021374 | CMS |
| ABBVIE INC. | $13.94 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105021376 | CMS |
| ABBVIE INC. | $25.00 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105021378 | CMS |
| Amgen Inc. | $20.67 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111650248 | CMS |
| Amgen Inc. | $11.00 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111650250 | CMS |
| Amgen Inc. | $19.02 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111650258 | CMS |
| Amgen Inc. | $18.54 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111650252 | CMS |
| Amgen Inc. | $12.52 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111650254 | CMS |
| Amgen Inc. | $21.99 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111650256 | CMS |
| Amgen Inc. | $28.24 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111650260 | CMS |
| Amgen Inc. | $26.40 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111650262 | CMS |
| Celgene Corporation | $15.29 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101180344 | CMS |
| GENZYME CORPORATION | $24.75 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139978131 | CMS |
| Novartis Pharmaceuticals Corporation | $21.18 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087003910 | CMS |
| Novartis Pharmaceuticals Corporation | $16.91 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087003916 | CMS |
| Organon Llc | $26.53 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136300358 | CMS |
| Organon Llc | $32.92 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136300360 | CMS |
| Sandoz Inc. | $24.70 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089368678 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.